Pediatrics

Host: Jennifer Shu, MD, FAAP

Guest: Lori Feldman-Winter, MD, MPH

Despite ambitious recommendations that new mothers breastfeed their infants for at least one year after birth, very few mothers meet this objective. Knowing there are barriers to breastfeeding--social, economic, and beyond--how can we help mothers get past these difficulties, where possible? Further, how can we allay the guilt many mothers feel when they're unable to breastfeed? For answers, host Dr. Jennifer Shu talks with Dr. Lori Feldman-Winter, associate professor of pediatrics at the University of Medicine and Dentistry of New Jersey, division head of adolescent medicine at Cooper University Hospital in Camden, N.J., and an Executive Committee member of the American Academy of Pediatrics section on breastfeeding.

Host: Leslie P. Lundt, MD

Guest: Gregory Zimet, PhD

Vaccines seem to always provoke controversy. Perhaps none so much as the HPV vaccine. Dr. Gregory D. Zimet, professor of pediatrics and clinical psychology at Indiana University School of Medicine, joins host Dr. Leslie Lundt to discuss the obstacles that may interfere with widespread acceptance of the HPV vaccine.

Host: Lisa Mazzullo, MD

Guest: Cynthia Wong, MD

Epidural anesthesia has changed dramatically since its introduction to the obstetric arena in the early 1970s. Now we have various types of epidurals we can administer during labor. One of the major obstacles for anesthesiologists is determining how women perceive pain during labor and how to administer the proper dosage of pain medication. Dr. Cynthia Wong, associate professor of anesthesiology at Northwestern University's Feinberg School of Medicine, joins host Dr. Lisa Mazzullo to discuss these issues, and her recent study that looks at the rate of Cesarean deliveries when epidural anesthesia is administered at different times during labor.

Host: Lauren Streicher, MD

Guest: Sharmila Makhija, MD

We are finding the highest prevalence of human papillomavirus (HPV) among women in their early 20s, but the FDA now recommends that an HPV vaccine be administered to women up to the age of 45. Why? Because recent research tells us that the at-risk population may be larger than we think. Dr. Sharmila Makhija, associate professor of gynecologic oncology at Emory University School of Medicine, weighs the pros and cons of this new recommendation with host Dr. Lauren Streicher.

Host: Mark Nolan Hill, MD

Guest: Randi Hagerman, MD

Diagnosis of the genetic disorder Fragile X syndrome can be devastating for our young patients and their families, knowing that both the patient and their elders can be affected by this condition. Should we expand current screening measures for Fragile X? As clinicians, how do we guide patients and their families through this process of understanding their diagnosis? Dr. Randi Hagerman, professor and endowed chair of Fragile X research, and medical director of the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute at the University of California, Davis School of Medicine, joins host Dr. Mark Nolan Hill to talk about the nuances of this genetic condition.

Host: Mark Nolan Hill, MD

Guest: Randi Hagerman, MD

We are rapidly learning more about the genetic disorder Fragile X syndrome, and a series of conditions related to Fragile X. We're also seeing great progress in promising therapies under investigation. How will these therapies, along with other treatment strategies, improve the lives of children and families affected by Fragile X and related conditions? Who should supervise care, and should treatment for children be coordinated with care of potentially affected relatives? Dr. Randi Hagerman, professor and endowed chair of Fragile X research, and medical director of the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute at the University of California, Davis School of Medicine, shares her expansive expertise on Fragile X syndrome and associated conditions with host Dr. Mark Nolan Hill. If a child is diagnosed with Fragile X, is genetic screening inevitably warranted for parents and grandparents?

Host: Mark Nolan Hill, MD

Guest: Randi Hagerman, MD

It's responsible for more than five percent of all cases of autism, and it's the most common cause of inherited mental retardation. But are we as familiar as we need to be with Fragile X syndrome, and a series of genetic conditions related to Fragile X? Host Dr. Mark Nolan Hill welcomes Dr. Randi Hagerman, professor and endowed chair of Fragile X research, and medical director of the Medical Investigation of Neurodevelopmental Disorders (MIND) Institute at the University of California, Davis School of Medicine, for a stimulating conversation about our rapidly expanding knowledge of these genetic conditions. How do the signs and symptoms manifest in children, and how does Fragile X impact our elder generations?

Host: Mark Nolan Hill, MD

Guest: Jamie Hutchison, MD

A young patient is brought into the emergency department having suffered a traumatic brain injury. Hypothermia may be considered as part of the treatment regimen. If so, how soon after the injury should treatment begin, and how long should treatment last? Dr. Jamie Hutchison, associate professor of critical care medicine and pediatrics at the University of Toronto, and research director of critical care medicine at the Hospital for Sick Children in Toronto, explains the mechanism used for cooling and examines potential links between data on hypothermia treatment for adults and similar therapy for children. Dr. Mark Nolan Hill hosts.

Host: Mark Nolan Hill, MD

Guest: Jamie Hutchison, MD

Traumatic brain injuries can present a lifetime of consequences. Previous studies indicate that hypothermia may be a viable treatment option, but little data has demonstrated efficacy for our youngest patients. Is hypothermia effective in treating pediatric brain trauma patients in a more rigorous research setting? What are the key mechanisms behind this query? Dr. Jamie Hutchison, associate professor of critical care medicine and pediatrics at the University of Toronto, and research director of critical care medicine at the Hospital for Sick Children in Toronto, evaluates the utility of hypothermia treatment for pediatric traumatic brain injuries with host Dr. Mark Nolan Hill.

Host: Gary Kohn, MD

Guest: Robert C. Fifer, PhD

Dr. Robert C. Fifer, associate professor and director of audiology and speech-language pathology at Mailman Center for Child Development, in the department of pediatrics at University of Miami School of Medicine, talks with host Dr. Bruce Bloom about what physicians need to know about speech and language development. What are other likely causes of slow development? When should chronic otitus media be a concern?